Nature's Sunshine Products (NATR) Investor presentation summary

Market position and performance

• Operations span 40+ countries; the global addressable market was $1.1T in 2024, with projected 7.1% CAGR for 2025e–2029.

• Revenue CAGR was 4% versus (2%) for peers, and adjusted EBITDA CAGR was 16% versus (12%) for peers.

• Total shareholder return was 141% versus 66% for the Russell 2000 from Jan. 1, 2023 through July 30, 2026.

Growth ambition

• Long-term goals are $1B in revenue and 15% EBITDA; the vision is to become a global leader in natural health supplements.

• The illustrative roadmap starts from 2025 revenue of $480M and identifies market, digital, geographic, channel and M&A growth; estimates are directional aspirations, not guidance or forecasts.

• An illustrative EBITDA margin bridge targets 15.0% from 10.3% in 2025 through gross margin, business mix, G&A and M&A levers; not guidance or a forecast.

Growth strategy and channels

• Four growth drivers: geographic penetration and expansion, digital and channel expansion, superior marketing, and M&A.

• US supplement eCommerce was 23% of the market, with 10% forecast CAGR; 2025–2028e growth shown at 34% for eCommerce, 20% for mass market and 12% for natural and specialty retail.

• Digital sales reached $40M in five years, doubling since 2022; US channels include specialty retail, direct-to-consumer, health practitioners and independent consultants.

• Subscription programs represented 40% of 2025 Japan sales, 23% of Taiwan sales and 32% of digital sales; chart values are annualized quarterly results.